ampelopsin has been researched along with Cancer of Stomach in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XB; DU, JL; Wang, FJ; Wang, WS; Yuan, DP; Zong, XY | 1 |
| Dong, T; Huang, M; Jiang, M; Lv, J; Wu, M; Xu, L; Xue, M | 1 |
| Cai, T; Ge, F; Qi, S; Qi, Z; Wang, S | 1 |
| Fang, XD; Fu, LB; Ji, FJ; Jin, HY; Liu, XW; Tian, XF; Wu, YY | 1 |
4 other study(ies) available for ampelopsin and Cancer of Stomach
| Article | Year |
|---|---|
[Effects of dihydromyricetin on the migration and invasion of human gastric cancer MKN45 cells and its mechanism].
Topics: Cadherins; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Flavonols; Gene Expression Regulation; Humans; Neoplasm Invasiveness; Stomach Neoplasms; Vimentin | 2019 |
Reversal Effect of Dihydromyricetin on Multiple Drug Resistance in SGC7901/5-FU Cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavonols; Fluorouracil; Humans; Stomach Neoplasms; Tumor Cells, Cultured | 2020 |
[Dihydromyricetin inhibits proliferation and migration of gastric cancer cells through regulating Akt/STAT3 signaling pathways and HMGB1 expression].
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Flavonols; HMGB1 Protein; Humans; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor; Stomach Neoplasms | 2021 |
Dihydromyricetin induces cell apoptosis via a p53-related pathway in AGS human gastric cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flavonols; Gene Expression Regulation, Neoplastic; Humans; Signal Transduction; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2015 |